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Abstract. We have sampled 102 adult horses, of both sexes. The horses were placed into two 
categories, SIRS (37 horses) and non-SIRS, based on their fibrinogen, blood MPXI and serum iron 
values. The blood work of the SIRS-diagnosed horses was then evaluated to highlight possible 
connections to the diagnosis, especially in terms of the leukopenia/leukocytosis that are considered 
markers of SIRS in human medicine.  
Only half of these horses showed symptoms of leukocytosis/leukopenia in addition to high 
fibrinogen and low serum iron and MPXI, therefore showing that the algorithm used in human 
medicine cannot be applied to horses in its whole. 
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INTRODUCTION 
Maybe one of the most frequent and serious problems of the equine clinician is the 
management of systemic responses to infection and/or trauma of the patient.  
Systemic inflammatory response syndrome (SIRS) is a term that has been developed 
for the understanding of the clinical response towards a non-specific insult and includes one or 
more variables (rectal temperature over38oCor under 36oC, heart beat over 90 bpm, respiratory 
rate over 20 breaths/min, WBC over 12000/mm3, or under 4000/mm3 and/or over 10% 
bands.It is important to understand that proofs of bacteremia will not necessary lead to SIRS 
or sepsis (SIRS + proof of infection) (Davies and Hagen, 1997, Oikawa et al., 2003). 
Indifferently from its etiology, SIRS has the same pathophysiology pathwayswith minor 
differences. This syndrome is quite physiological up to a certain point (Tello, 2005). Next to 
the already known normal inflammatory mechanisms that are practically exaggerated in this 
syndrome and the lack of balance between pro and anti-inflammatory cascades (MacIntire et 
al., 2006, Walsh, 2005), there also is a ‚multi-hit’ theory, stating that the primary injury that 
leads to SIRS being initiated is followed by multiple events that induce an exaggerated 
response and lead to a clinical manifestation (Burdette et al., 2009). 
Neutrophilsplay a pivot role in SIRS and can be activated by numerous stimuli via 
receptor systems in their surfaces (TNFα, IL-1, IL-8, LT etc) (Davies and Hagen 1997). SIRS 
also associates with hypercoagulability states, and shows increase in morbidity and mortality 
of patients with acute systemic disease that are also affected by coagulation status disorders 
(DallapSchaeret al, 2009). Acute phase proteins-APPare a group of blood proteins whose 
concentration alters depending on external/internal injury (Eckersall, 2000) whose 
concentration in the blood stream is directly connected to injury degree and tissue lesion, so 
they can be viewed as a useful tool in assessing progression of SIRS and prognosis (Murata et 
al, 2004). Of these APP’s, fibrinogen is considereda useful tool, and even though its reaches 
maximum values in 2-3 days after induction of inflammation, (Borges et al., 2007), it is the 
most handy tool in the diagnosis of systemic inflammation. The myeloperoxidase index is a 
neutrophil activation marker, used in human medicine and useful in the diagnosis of 
SIRS(Monaco, et al., 2005).PMN rich in MPO have positive MPXI values, whereas PMN 
lacking in MPO have negative values, which would be the case of systemic inflammation 
degranulation (Grulke et al, 2008).Recently, Schwarz et al. (2011) have studied the evolution 
of the MPXI in the equine and determined a certain prognostic values of the marker. 
This study has aimed to determine the general inflammatory status of the horses 
(fibrinogen, serum iron and MPXI) and see whether changes in the CBC 
(leukocytosis/leukopenia especially) appear at the same time and can be used as diagnostic 
tools. 
 
MATERIALS AND METHODS 
The biological material was represented bya total of 102 samples from different horse 
breeds, mainly lighter breeds (Shagya, Austrian Warm blood, Holstein, etc) with 59.80%, 
followed by ponies (Island, Fjord, Falabellaetc) with 21,56%, 15.68% half-breeds and a small 
percentage of heavy breeds, of 1,96% (Noriker). The sexes of the horses were evenly 
distributed (43.14% mares, 45.09% geldings and 10.78% stallions) and all were adults. 
The blood was sampled through jugular vein punction, in vacutainers with EDTA as 
the anticoagulant, and in certain cases, depending on the desired tests, with no anticoagulant. 
All samples were accompanied by a short history, defined simply so as to underline the reason 
of presentation and was one of five categories: colic, fever, anorexia/cachexia,diarrhea (no 
other symptoms) or other (diverse).Also, all samples were categorized depending on the 
diagnosis in 11 classes: gastro intestinal problems- surgical, gastro intestinal problems- non 
surgical, peritonitis, inflammatory bowel disease, tumors, castration complications, 
parasitosis, strangles and complications, viral pyrexia, healthy and non-gastro intestinal 
(anything else). 
We have used the ADVIA 120 analyzer by Siemensfor hematology, which is based on 
laser technology, with animal-specific software. This analyzer offers a complete blood count 
(CBC), White Blood Cell differential (Diff), as well as reticulocyte analysis (Retic-) and 
peroxidase and MPXI determinations. All these tests can be performed on a single blood 
aspirate. For blood chemistry, a basic chemistry was performed, in most cases including 
fibrinogen and iron. 
 
RESULTS AND DISCUSSIONS 
 
 The history of the animals was analyzed depending on the reason of presentation. The 
leading symptom for which the animals were presented for a consult was colic (54.9%), 
followed by fever (of unknown origin-FUO, or chronic) and then anorexia/cachexia. The most 
common diagnosis was by far peritonitis (29.41%), followed by non-surgical gastro-intestinal 
issues (20.58%), surgical gastro-intestinal problems (14.70%), tumors and parasitosis (each 
7.84%), healthy and non-GI related diagnosis (5.88% each), viral infections and castration 
complications (each 3.92%), strangles (1.96%) and IBD (0.98%). The diagnosis for SIRS was 
determined based on clinical symptoms and the use of three markers: serum iron, fibrinogen 
and MPXI, and the animals were grouped as healthy, with local inflammation, SIRS and 
sepsis (which can overlap), by using the reference intervals established by Schwarz et al., 
2011 and Borges et al., 2007 (Table 1). 
Tab 1.  
Reference intervals for fibrinogen, serum iron and MPXI (Schwarz et al 2011, Borges et al., 2007) 
 
Group Fibrinogen (g/L) Iron (lmol/L) MPXI 




9.8( 3.6 – 16) 
Local 
inflammation 
 2.33 (0.70–3.96)  
mg/dl 277 +/- 138 
20.9 (1.2–32.9) 
µg/dl 123 +/- 45 
10.6 (4.6 -16.6) 
SIRS 2.57 (0.76–4.37) 
mg/dl 445 +/- 213 
17.1 (0–31.0) 
µg/dl 64 +/- 45 
-0.3 (-8.4 - 7.8) 
Sepsis 3.01 (0.90–5.13) 12.1 (0–21.4) 7.9 (-2.5 – 18.3) 
 
41,37 % of the patients where we have determined all inflammatory markers did suffer from 
SIRS, with small MPXI values, as well as an increase in fibrinogen and decrease of serum 
iron. 44% of patients suspected of SIRS had leukocytes counts within reference intervals, 
56% showed either leukopenia or leukocytosis. That means that almost half of patients show 
no significant alterations of the CBC which is proof that the whole panel needs to be 
evaluated with a critical eye and correlated with the clinical symptoms and inflammatory 
markers. Of the 102 sampled patients, 91.17% (n= 93) were sent home, and the rest (8.83%, 9 
patients) have either been euthanized or have died. 
 Fibrinogen is an acute phase protein that increases degranulation, the phagocytosis, 
antibody-dependent cellular cytotoxicity and apoptosis slowdown. Traditionally, fibrinogen is 
considered to be a marker of infection immediately, but in fact its values increase to 24-48 
hours to induce inflammation and reach maximum than at 2-3 days after it also in healthy 
horses there are a variety of values of fibrinogen (0.0 to 2.50 g/L- Oukacha et al., 2005 or 2-4 
g/l-1, Tamzali et al., 200, Borges et al. 2007, 100-200 mg / dl etc) and the classical method of 
determination (heatprecipitation) is insensitive to subtle changes (Borges et al., 2007). 
Although fibrinogen is not the most specific APP in horses, it is the inflammatory marker 
most handy and can be used successfully in the clinic, as long as for the interpretation of the 
results, its delayed reactivity will be taken into account. This marker is useful in patients who 
are brought to the consultation though, as most horses are presenting in the clinic only after a 
certain time of manifestation of symptoms, therefore fibrinogen has time to 
increase.Fibrinogen is not indicated as a marker for monitoring the onset of SIRS (eg post-
op), due to not reacting promptly.  
Iron is found to be a sensitive marker of systemic inflammation, being seized at the 
cellular level (macrophages, hepatocytes) in states of inflammation, because of pro 
inflammatory cytokines (Borges et al., 2007, Smith and Cipriano, 1987). Serum iron 
decreases very rapidly when systemic inflammatory processes are initiated(Kemna et al., 
2005), so monitoring is useful in the diagnosis of SIRS. In our case, most patients with SIRS 
had abnormally low (below 100 µg/dl)serum iron, correlated with increased fibrinogen and 
reduced myeloperoxidase index.  
Granules containing myeloperoxidase in PMN's merge with phagozomes and kill 
phagocytized microbes, releasing their contents into the extracellular space (Deby- Dupont et 
al., 1999, Nauseef, 2007).In horses with severe gastrointestinal disease, particularly 
strangulated bowel obstructions, elevated levels of MPO in plasma and peritoneal fluid 
appear, thus having low values MPXI. The myeloperoxidase index is used as a marker of 
neutrophil activation and therefore systemic inflammation. MPXI is an index of per leucocyte 
MPO content and is thus an indicator of the relative activity of intracellular MPO,MPO-rich 
PMNhave positive MPXIvalues, while PMN depleted of MPOhad negativeMPXI values, eg 
degranulation in systemic inflammation (Grulke et al., 2008). In the horse, negative 
MPXIvalues are a good indicator of systemic inflammation, especially when correlated with 
fibrinogen and serum iron. The pathophysiology of SIRS and the diagnostic criteria borrowed 
from human medicine suggest that leukopenia or leukocytosis, along with some other criteria 
(body temperature, respiration, and pulse) should reflect the state of general inflammation 
(Bone et al., 1997, Levy et al., 2003).However, by the data we collected, it appears that many 
of the horses with SIRS had normalWBC counts, with only half of the samplesproving the 
presence of SIRS through leukopenia / leukocytosis. 37 of the horses that had various 
parameters determined were diagnosed with SIRS. Of these, almost half (44.4%) had 
leukocyte values in the normal range, and the others having very small or extremely high 
values of leukocytes. Thus, the criterion borrowed from human medicine to determine 
leukocytes and use that test as one of the steps in the SIRS diagnostic algorithm appears to no 
longer be valid in light of these results. 
 The relative and absolute leukocyte count and routine haematological values do not 
accurately reflect a generalized inflammatory state, but only helps the clinician to assess the 
patient's condition as a useful tool in the diagnosis of primary disease and establishment of the 
correct treatment. Regarding SIRS, it is important to take into account the fact that 
thesyndromehas a multiple etiology, although it can often be caused by colic and frequently 
accompanied endotoxaemia, it is not limited to these, in some cases it can occur for other 
reasons, such as trauma or other powerful injuries with a different cause than GI tract 
issues.This study was conducted in a clinic of internal diseases, so the prevalent etiology of 
SIRS in our horses was according to specialization, but an increased frequency of SIRS in 
horses presented with surgical histories cannot be excluded. Trauma is a powerful trigger for 
SIRS in humans (Lenz et al., 2007), therefore it would be interesting to follow the body's 
cellular response, in order to obtain details about new possibilities for the diagnosis of SIRS. 
Of course, typically the type of trauma that triggers SIRS is an acute one, and sometimes 
certain equine body systems are failing to keep in step with each other, therefore a 
discrepancy even higher than the present one appears between the CBCand the true 
pathophysiological processes that occur in response to injury. In evaluating blood counts ina 
patient suspected of SIRS it should be noted that hematologic changes occur later, so that a 
normal leukocyte count or a physiological leukocyte picture are not a guarantee of non-SIRS 
patients. As we have seen above, nearly half of the patients with SIRS confirmed by MPXI, 
fibrinogen and serum iron present normal counts, proof that the CBC should be viewed with a 
critical eye and necessarily correlated with clinical symptoms and other laboratory tests. The 
inflammatory markers fibrinogen, MPXI and Fe are very useful in diagnosing systemic 
inflammation, but difficult to determine in a clinical setting, requiring special equipment.  
CONCLUSIONS 
 SIRS represents a diagnostic challenge for clinicians, so it is important to diagnose it 
as fast as possible, with any paraclinical test that is available. 
 Only half of patients diagnosed with SIRS had leukopenia / leukocytosis, the others 
had a normalleukocyte count.  
 Diagnostic criteria of SIRS in human medicine adapts poorly to equine medicine, 
leukopenia / leukocytosis reported in human medicine is not constant in the horses in the 
study.  
 MPXI and serum iron were found to be accurate indicators of systemic inflammation, 
with constant low values in SIRS patients.  
 Serum Fibrinogen increases over a period of 48 hours so that it cannot be considered a 
good indicator for monitoring the occurrence of SIRS.  
 A comprehensive evaluation of CBC’s of equines suspected of SIRS needs to be 
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